CREB1 and prostate cancer: Here we confirmed this conclusion, by showing that expressing activated CREB1 cDNA (Y134F), or treatment of CREB1 signaling activator Forskolin or ISO, increases H3K27me3 epigenetic mark in LNCaP and PC3 prostate cancer cells (Fig. 6A, B).